The Covid-19-causing coronavirus is mutating while spreading around the world in the pandemic, but none of the mutations currently documented appears to be making the SARS-CoV-2 virus able to spread more rapidly, scientists said.
Research Roundup: Can Flu and Pneumonia Vaccines Prevent Alzheimer’s and More
Alzheimer's Association International Conference, Alzheimer’s disease, Brain Cells, Cells, Clinical Trials, Duke University, Flu Vaccines, Genes, Genetic Database, Genomes, Herpes, Microbiome, Mutations, Pneumonia Vaccines, R&D, Researchers, Scientific studiesA review of recently published scientific studies includes a look at the potential of using flu and pneumonia vaccines to decrease the risk of developing Alzheimer’s disease.
British researchers will study the genes of thousands of ill COVID-19 patients to try to crack one of the most puzzling riddles of the novel coronavirus: why does it kill some people but give others not even a mild headache?
A series of studies of the genomes of thousands of samples of the new coronavirus show that SARS-CoV-2 is mutating and evolving while adapting to human hosts.
Dr. Anthony Fauci – who has been considered one of the most trusted leaders tackling the COVID-19 pandemic in the United States – once again stressed that, as far as the evidence suggests, the novel coronavirus is naturally occurring and was not made in a laboratory.
Research Roundup: Major Breakthrough in HIV Research and More
Australia, China, Coronavirus Disease 2019 (COVID-19), Drug Cocktails, Genes, Genetic Markers, Genomes, Germany, Herpes Simplex Virus, HIV, Immune Cells, Medical Journals, Mount Sinai, Neurodegenerative Diseases, New England Journal of Medicine, Nucleotides, R&D, RNA, San Francisco (UCSF), Science, Scientific studies, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Netherlands, Thrombosis Research, University of Alabama at Birmingham (UAB), University of Maryland Baltimore County, Walter and Eliza Hall InstituteA review of some recently published scientific studies, including researchers at the University of Maryland Baltimore County identifying a single nucleotide that controls two forms of the HIV virus’ RNA.
Illumina and Pacific Biosciences called off their $1.2 billion merger fourteen months after the deal was announced.
Researchers at the University of California, San Diego (UCSD) School of Medicine have identified a key switch that has the potential to eliminate dormant HIV reservoirs.
British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement to jointly develop five cancer-killing viral immunotherapies.
Personal Genome Diagnostics Collaborates with Merck on Global Clinical Trial Evaluating Response to Dual Biomarker Directed Precision Oncology Combination Therapy
Advanced Non-Small Cell Lung Cancer, Assays, Biomarkers, Business, Clinical Trials, Collaborations, Gene Expression, Genomes, Liquid Biopsies, Oncology, Tumor Biopsies, TumorsPersonal Genome Diagnostics Inc. reported that the cancer genomics company’s 500+ gene pan-cancer tumor profiling tissue assay is being used in Merck’s Phase 2 precision oncology KeyImPaCT study of biomarker-directed, pembrolizumab-based combination therapy for advanced non-small-cell lung cancer (KEYNOTE-495).